Abstract:Abstract Background Megakaryocytes (MKs), large progenitor cells residing in the bone marrow, are the source of platelets. In 2009, Colosetti P et al. reported that PMA and SB could induce megakaryocytic differentiation of the chronic myelogenous leukemia cell line K562 by triggering autophagy. It gives us the first insight of autophagy induction in in vitro megakaryocytic differentiation. Although Feng W et al. reported autophagy also exists in human platelets, the role of autophagy in megakaryocyte-platelet commitment axis remains poorly understood. In this study, we elucidated the biological effects of autophagy deficiency on megakaryopoiesis and thrombosis using hematopoietic system conditionally atg7 knockout mice. Methods and Materials To evaluate the biological effects of autophagy deficiency on platelets, the following experiments were performed: (1) complete blood count of wild type and atg7-/- mice, (2) the tail bleeding time assay of wild type and Atg7-/- mice, (3) the effect of atg7 knockout on platelet aggregation and activation of CD62P and JON/A (αIIbβ3) were analyzed by flow cytometry. To assess whether the observed changes in platelets of atg7-/- mice result in aberrations of megakaryopoiesis, the following experiments were performed: (1) the percentage of BM CD41+CD61+ cells was analyzed by flow cytometry, (2) the AchE activity assay of platelets and murine BM Lin- cells cultured with murine TPO and SCF, (3) Morphology of megakaryocytes derived from BM Lin- cells was evaluated by Wright-Giemsa staining, (4) megakaryocytic differentiation from BM Lin- cells was evaluated by CD41/forward-scatter (FSC) dot plot. To evaluate the role of reactive oxygen species in MK differentiation, the Lin- cells were stained with MitoTracker Green and MitoSox Red and then analyzed by flow cytometry. Results (1) The number of platelets in the peripheral blood of atg7-/- mice was significantly decreased (WT: 904.2±75.5, Atg7+/-: 942.8±136.3, Atg7-/-: 330.5±282.2, p<0.01), while the size of platelets (MPV) was increased compared with WT mice (WT: 5.6±0.1, Atg7+/-: 5.7±0.1, atg7-/-: 6.8±0.5, p<0.01). (2) The bleeding time was significantly longer (WT: 51.5±14.8s, Atg7-/-: 915.2±282.9s, p<0.01) and thrombin-induced platelet aggregation was decreased (WT: 97.5±2.5, Atg7+/-: 62.5±7.5, Atg7-/-: 7.75±7.25, p<0.05) in Atg7-/- mice than in wild-type mice. (3) The activation of CD62P (WT: 14.5±0.09, atg7+/-: 11.17±0.06, atg7-/-: 3.2±0.03, p<0.01) and JON/A (αIIbβ3) (WT: 48.1±0.1, atg7+/-: 13.5±0.1, atg7-/-: 5.9±0.2, p<0.01) was decreased in atg7-/- platelets. These results indicated that atg7-dependent autophagy is important for thrombosis and platelet function. (4) The percentage of CD41+CD61+ cells was decreased in bone marrow of atg7-/- mice (WT: 30.4±0.6, atg7+/-: 27.9±1.3, atg7-/-: 18.9±0.3, p<0.01). (5) In mice lacking autophagy, both the Lin- cells stimulated by TPO (WT: 0.35±0.03, atg7-/-: 0.22±0.05, p<0.01) and the platelets collected through the inferior vena cava (WT: 0.099±0.005, atg7-/-: 0.05±0.009, p<0.01) had significantly lower AChE activity compared with WT mice. (6) Low level of CD41+/FSChigh cells were seen in the in vitro culture of atg7-/- BM Lin- cells with TPO and SCF ( WT:5.6±2.2, Atg7-/-: 0.2±0.03, p<0.01). These results reflected a significant reduction in MK differentiation from autophagy defective hematopoietic progenitors. An accumulation of mitochondria (WT: 547.3±7.0, atg7-/-: 737.8±126.6, p<0.01) and mitochondrial superoxide (WT: 280.2±4.8, atg7-/-: 343.8±42.4, p<0.05) was found in atg7-/- BM Lin- cells, which may severely disturb the progress of MK differentiation. Conclusion Autophagy is essential for the megakaryopoiesis and thrombosis by maintaining mitochondrial homeostasis. Elevated reactive oxygen species might be the cause of megakaryocytic differentiation blockade. Disclosures No relevant conflicts of interest to declare.

Endothelial-specific deletion of autophagy-related 7 (ATG7) attenuates arterial thrombosis in mice

Endothelial-specific Expression of Mitochondrial Thioredoxin Improves Endothelial Cell Function and Reduces Atherosclerotic Lesions.

Loss of Atg7 in Endothelial Cells Enhanced Cutaneous Wound Healing in a Mouse Model

Ablation of endothelial Atg7 inhibits ischemia-induced angiogenesis by upregulating Stat1 that suppresses Hif1a expression

Endothelial Specific Deletion of Autotaxin Improves Stroke Outcomes

Endothelial Autophagy Promotes Atheroprotective Communication Between Endothelial and Smooth Muscle Cells via Exosome-Mediated Delivery of miR-204-5p

Effect of Autophagy Regulated by Sirt1/FoxO1 Pathway on the Release of Factors Promoting Thrombosis from Vascular Endothelial Cells

Impaired Autophagy in CD11b+ Dendritic Cells Expands CD4+ Regulatory T Cells and Limits Atherosclerosis in Mice

Intact endothelial autophagy is required to maintain vascular lipid homeostasis

ADAMTS-7 Inhibits Re-endothelialization of Injured Arteries and Promotes Vascular Remodeling Through Cleavage of Thrombospondin-1

Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways

Loss of Autophagy Leads to Megakaryocytes Differentiation Failure and Defective Platelets Function

Targeted Disruption Of Cd73/Ecto-5 '-Nucleotidase Alters Thromboregulation And Augments Vascular Inflammatory Response

Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis

2182Sirtuin 5 regulates arterial thrombosis by modulating endothelial plasminogen activator inhibitor-1

Abstract 1042: Vascular Adamts7 Promotes Smooth Muscle Foam Cell Formation During Atherosclerosis

Endothelial-Specific Deficiency of ATG5 (Autophagy Protein 5) Attenuates Ischemia-Related Angiogenesis

Abstract 139: Precision Nanomedicine Targeting Novel Endothelial Mechano-sensing Mechanisms To Treat Vascular Diseases

Targeting mechanosensitive endothelial TXNDC5 to stabilize eNOS and reduce atherosclerosis in vivo

Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expression.